A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
This accidental discovery, made by medical biochemist Henry Pownall, Ph.D., and his team at the Houston Methodist Research Institute, reveals a new pathway in the cholesterol-elimination chain that will be key to developing new drugs to lower cholesterol. Their findings are described in an article titled “ABCA1-Derived Nascent High Density Lipoprotein-Apo AI and Lipids Metabolically Segregate,” appearing online Oct. 26 and in print Nov. 21 in the American Heart Association’s Arteriosclerosis, Thrombosis, and Vascular Biology journal.
VIDEO: Dr. Pownall explains the research https://vimeo.com/239663429
Pownall, who is the corresponding author, said the initial purpose of their study was to prove the current model of cholesterol transport through the body was correct. It turns out, however, that the model was not quite right.
“The model people have been using for 40 years presumed that cholesterol was transported from the arteries with other lipids and proteins and entered a particle that stayed in the blood for several days before being cleared by the liver for disposal,” Pownall said. “What we discovered in the process was something different. We discovered the cholesterol skips all these steps and goes directly from this early particle to the liver in two minutes. This is a thousand times faster than what was formerly suspected.”
While most studies look at HDL cholesterol in its mature form found in blood, Pownall and his colleagues studied cholesterol in nascent HDL, an early form of HDL produced by cells. Cholesterol in the nascent HDL goes directly to the liver, largely skipping conversion to the mature form of HDL
Pownall stresses that it’s not that current practices of treating “bad” LDL cholesterol are incorrect, but instead that physicians and researchers need to better understand how the “good” HDL cholesterol contributes to cardiovascular disease and how to raise it in a way that protects the heart, because some patients with very high HDL numbers, which were always thought to be beneficial, are actually at risk.
“LDL cholesterol, the so-called ‘bad cholesterol’ is well controlled with the current statin therapies. The track record for these cholesterol-lowering drugs is indisputable, and they will continue to work,” Pownall said. “HDL, or the ‘good cholesterol,’ however, is a much trickier system. Not everything that raises it protects the heart and not everything that lowers it is bad for you. We will need to redesign new drugs to lower plasma cholesterol in a way that takes into account this new mechanism. We will look for interventions – maybe dietary, maybe pharmacological – that raise HDL cholesterol in a way that helps protect the arteries and prevent cardiovascular disease.”
Researchers collaborating with Pownall on this paper were Bingqing Xu, Baiba K. Gillard, Antonio M. Gotto Jr., and Corina Rosales, and the work was supported by a High-density Lipoprotein (HDL) Biogenesis and Speciation grant from the National Institutes of Health’s National Lung, Heart and Blood Institute (R01HL129767), Deutsche Forschungsgemeinschaft (Exc114-2) and Fondren Foundation.
For more information: ABCA1-Derived Nascent High Density Lipoprotein-Apo AI and Lipids Metabolically Segregate. Arteriosclerosis, Thrombosis, and Vascular Biology DOI: https://doi.org/10.1161/ATVBAHA.117.310290 (Oct. 26, 2017) B. Xu, B.K. Gillard, A.M. Gotto Jr., C. Rosales, H.J. Pownall.
Subscribe to Borne the Battle in iTunes and have these powerful Veteran stories delivered straight to your device e… https://t.co/MFb2CmjQ2k
Wanna MEAT🍖 for lunch? NBA Hall of Famer & UH alumnus Clyde ‘The Glide' Drexler brings new BBQ restaurant to SC Sa… https://t.co/CCJALbAJLM
Memorial Hermann Cypress Hospital & @CyFairISD are promoting physical activity in elementary school classrooms thro… https://t.co/hx4aB6hiYp
TAMU Health Sciences@TAMHSC
#Conjuctivitis (#PinkEye) is one of the most common eye infections. Here's what you need to know to keep it at bay: https://t.co/J4nuFBidUT
Rice researchers attended the University Innovation & Entrepreneurship Showcase to demonstrate SNOWater, a solar wa… https://t.co/HsexnxBWVp
Powering through pain is often seen as a sign of strength, but when do we reach our limit? @BCMEthics’ Julia Jung e… https://t.co/R4lEKkCljU
Baylor College of MedicineBaylorCollegeOfMedicine
Powering through pain is often seen as a sign of strength, but when do we reach our limit? Baylor College of Medicine Center for Medical Ethics and Health Polic...
RT @VEWotring: Surgery in space? So excited about today's Science Friday! George Pantalos will discuss his new project funded by Translati…
RT @BCMHouston_News: Uptick in #mumps cases prompts 2 Texas prisons to close to visitors, but @bcmhouston infectious disease expert says ou…
CHI St Luke's Health@CHI_StLukes
Dr. Jeremiah Johnson, endovascular neurosurgeon at Baylor St. Luke’s Certified Comprehensive Stroke Center: “This [… https://t.co/vJLqRUYehS
TAMU Health Sciences@TAMHSC
An associate professor from @TAMU_SPH represented @TAMU at the inaugural University Innovation and Entrepreneurship… https://t.co/nUw5MbpsCI
ICYMI: @USCG #VeteranOfTheDay Alexander G. Thompson Jr. served aboard the USS Ingham from during #WWII… https://t.co/15uRIQCNld
RT @SallyMacFox26: Deep laceration thanks to @UTHealth clinical nurse educator, Kennessa, who is transforming dozens of students into victi…
Dog owners may have decreased risk of heart disease and mortality, new study suggests. https://t.co/8pwNcDTmgO